I43M (p.Ile43Met) variant of SGCD (Delta-sarcoglycan)

I43M (p.Ile43Met) in SGCD (Delta-sarcoglycan) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.56 / 1. The record also includes structural context.

I43M (p.Ile43Met) variant details